Related Experiment Video
Updated: Mar 14, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
"How I manage" IgG4-Related Disease
Emanuel Della-Torre1, John H Stone2,3
1Unit of Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
Immunoglobulin G4-related disease (IgG4-RD) involves complex immune cell interactions. Current IgG4-RD management is based on expert experience due to limited clinical trials, highlighting common dilemmas and expert approaches.
Area of Science:
- Immunology
- Rheumatology
- Pathophysiology of immune-mediated diseases
Background:
- Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition.
- It involves intricate interactions between B and T lymphocytes.
- A specific CD4+ cytotoxic T lymphocyte expressing SLAM-F7 is implicated as a key driver, sustained by B cell antigen presentation.
Purpose of the Study:
- To address the challenges in managing IgG4-related disease.
- To outline expert approaches to common clinical dilemmas in IgG4-RD management.
- To provide guidance in the absence of extensive clinical trial data.
Main Methods:
- Review of clinical experience from leading expert centers.
- Identification and discussion of six common management dilemmas in IgG4-RD.
- Description of typical management strategies employed by experts.
Main Results:
- IgG4-RD management is currently more art than science due to limited prospective studies.
- Six prevalent clinical management dilemmas were identified.
- Expert-driven approaches to these dilemmas are detailed.
Conclusions:
- Understanding IgG4-RD pathophysiology is advancing, promising future targeted therapies.
- Current management relies heavily on accumulated clinical expertise.
- Addressing common dilemmas with established approaches is crucial for patient care in IgG4-RD.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Irritable Bowel Syndrome III: Medical and Nursing Management